Reed Joshua 4
4 · Omega Therapeutics, Inc. · Filed Oct 28, 2022
Insider Transaction Report
Form 4
Reed Joshua
Chief Financial Officer
Transactions
- Award
Option (Right to Buy)
2022-10-27+55,000→ 55,000 totalExercise: $5.27Exp: 2032-10-26→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable as to 25% of the underlying shares on October 27, 2023 and as to 6.25% of the underlying shares upon the Reporting Person's completion of each three full months of continued service to the Issuer thereafter, such that the option will be fully vested and exercisable on October 27, 2026.